高级检索
当前位置: 首页 > 详情页

A microRNA-related single nucleotide polymorphism of the Dicer gene is associated with risk of dermatomyositis

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]Department of Immunology and Rheumatology, The Second Hospital of Hebei Medical University, Shijiazhuang, China [2]Department of Immunology and Rheumatology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China
出处:
ISSN:

关键词: DM MiRNAs SNPs Cytokine

摘要:
Objectives: To evaluate the correlation of miRNA-related single nucleotide polymorphisms (miR-SNPs) with the risk of dermatomyositis (DM) development.Introduction: MicroRNAs (MiRNAs) are involved in a variety of activities such as cell differentiation, proliferation, apoptosis, tumorigenesis, and immunological response. MiR-SNPs alter the expression levels of miRNAs, leading to increased susceptibility to DM. Methods: We genotyped six miR-SNPs for miRNA processing machinery genes, including XPO5 (rs11077), RAN (rs14035), Dicer (rs3742330), TNRC6B (rs9623117), GEMIN3 (rs197412), and GEMIN4 (rs2740348), and two miR-SNPs for microRNA binding site, including SET8 (rs16917496), and KRT81 (rs3660), in a case-control study to assess the impact of these miR-SNPs on DM risk. Then we assessed cytokine expression and ROS levels in DM to determine the relationship between risk-related miR-SNPs and cytokines. Results: We discovered that Dicer's (rs3742330) AA genotype had a decreased chance of developing DM than the AG + GG type (odds ratio, 0.527; 95% confidence interval: 0.281-0.987; p = 0.045). The subsequent analysis showed that the AA genotype carrier had greater levels of IL-4 (p = 0.034). Conclusion: The SNP of Dicer (rs3742330) maybe an attractive predictor of DM, moreover the cytokine of IL-4 may act as the factor that distinguishes SNP of Dicer (rs3742330) into AA and AG + GG.

语种:
被引次数:
WOS:
中科院分区:
出版当年[2023]版:
大类 | 4 区 医学
小类 | 4 区 免疫学
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 免疫学
JCR分区:
出版当年[2023]版:
Q4 IMMUNOLOGY
最新[2023]版:
Q4 IMMUNOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2023版] 出版当年五年平均 出版前一年[2022版]

第一作者:
第一作者机构: [1]Department of Immunology and Rheumatology, The Second Hospital of Hebei Medical University, Shijiazhuang, China
通讯作者:
通讯机构: [2]Department of Immunology and Rheumatology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China [*1]Department of Immunology and Rheumatology, The Fourth Hospital of Hebei Medical University, 12 Jiankang Road, Shijiazhuang 050011, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:39770 今日访问量:0 总访问量:1333 更新日期:2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 河北医科大学第四医院 技术支持:重庆聚合科技有限公司 地址:河北省石家庄市健康路12号